A Study of AL721 in HIV-Infected Patients With Swollen Lymph Nodes

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00001012
Recruitment Status : Completed
First Posted : August 31, 2001
Last Update Posted : June 24, 2005
Information provided by:
National Institute of Allergy and Infectious Diseases (NIAID)

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Primary Completion Date : No date given
  Study Completion Date : No date given
Mildvan D, Armstrong D, Antoniskis D, Sacks H, Balfour H, Buzas J, Pettinelli C. An open label dose-ranging trial of al721 in pgl and ARC. Int Conf AIDS. 1989 Jun 4-9;5:403 (abstract no WBP312)